Autophagy 2015-01-01

A novel mechanism of autophagic cell death in dystrophic muscle regulated by P2RX7 receptor large-pore formation and HSP90.

Christopher N J Young, Anthony Sinadinos, Alexis Lefebvre, Philippe Chan, Stephen Arkle, David Vaudry, Dariusz C Gorecki

Index: Autophagy 11(1) , 113-30, (2015)

Full Text: HTML

Abstract

P2RX7 is an ATP-gated ion channel, which can also exhibit an open state with a considerably wider permeation. However, the functional significance of the movement of molecules through the large pore (LP) and the intracellular signaling events involved are not known. Here, analyzing the consequences of P2RX7 activation in primary myoblasts and myotubes from the Dmd(mdx) mouse model of Duchenne muscular dystrophy, we found ATP-induced P2RX7-dependent autophagic flux, leading to CASP3-CASP7-independent cell death. P2RX7-evoked autophagy was triggered by LP formation but not Ca(2+) influx or MAPK1-MAPK3 phosphorylation, 2 canonical P2RX7-evoked signals. Phosphoproteomics, protein expression inference and signaling pathway prediction analysis of P2RX7 signaling mediators pointed to HSPA2 and HSP90 proteins. Indeed, specific HSP90 inhibitors prevented LP formation, LC3-II accumulation, and cell death in myoblasts and myotubes but not in macrophages. Pharmacological blockade or genetic ablation of p2rx7 also proved protective against ATP-induced death of muscle cells, as did inhibition of autophagy with 3-MA. The functional significance of the P2RX7 LP is one of the great unknowns of purinergic signaling. Our data demonstrate a novel outcome--autophagy--and show that molecules entering through the LP can be targeted to phagophores. Moreover, we show that in muscles but not in macrophages, autophagy is needed for the formation of this LP. Given that P2RX7-dependent LP and HSP90 are critically interacting in the ATP-evoked autophagic death of dystrophic muscles, treatments targeting this axis could be of therapeutic benefit in this debilitating and incurable form of muscular dystrophy.

Related Compounds

Structure Name/CAS No. Articles
2'- AND 3'-O-(4-BENZOYLBENZOYL)-ADENOSINE 5'-TRIPHOSPHATE TRIETHYLAMMONIUM SALT Structure 2'- AND 3'-O-(4-BENZOYLBENZOYL)-ADENOSINE 5'-TRIPHOSPHATE TRIETHYLAMMONIUM SALT
CAS:112898-15-4
Iodoacetamide Structure Iodoacetamide
CAS:144-48-9
TMRE Structure TMRE
CAS:115532-52-0
Tris(2-carboxyethyl)phosphine Hydrochloride Structure Tris(2-carboxyethyl)phosphine Hydrochloride
CAS:51805-45-9
Triton X-100 Structure Triton X-100
CAS:9002-93-1
Sodium orthovanadate Structure Sodium orthovanadate
CAS:13721-39-6
3-Methyladenine Structure 3-Methyladenine
CAS:5142-23-4
Digitonin Structure Digitonin
CAS:11024-24-1
E-64d Structure E-64d
CAS:88321-09-9
Lucifer Yellow CH dilithium salt Structure Lucifer Yellow CH dilithium salt
CAS:67769-47-5